2020
DOI: 10.3390/genes11101174
|View full text |Cite
|
Sign up to set email alerts
|

Characterization of Hormone-Dependent Pathways in Six Human Prostate-Cancer Cell Lines: A Gene-Expression Study

Abstract: Prostate cancer (PCa), the most incident cancer in men, is tightly regulated by endocrine signals. A number of different PCa cell lines are commonly used for in vitro experiments, but these are of diverse origin, and have very different cell-proliferation rates and hormone-response capacities. By analyzing the gene-expression pattern of main hormone pathways, we systematically compared six PCa cell lines and parental primary cells. We compared these cell lines (i) with each other and (ii) with PCa tissue sampl… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2020
2020
2023
2023

Publication Types

Select...
4

Relationship

2
2

Authors

Journals

citations
Cited by 4 publications
(2 citation statements)
references
References 40 publications
(55 reference statements)
0
2
0
Order By: Relevance
“…Franco et al reported that differences in expression of genes in six prostate cancer cell lines were accounted for by hormone‐dependent cell pathways, including the AR pathway (Franko et al, 2020). miR‐27a‐3p was posited to be a tumour suppressor or an oncogene in multiple cancers such hepatocellular carcinoma, pancreatic, bladder, colon and breast cancers (Li et al, 2019).…”
Section: Discussionmentioning
confidence: 99%
“…Franco et al reported that differences in expression of genes in six prostate cancer cell lines were accounted for by hormone‐dependent cell pathways, including the AR pathway (Franko et al, 2020). miR‐27a‐3p was posited to be a tumour suppressor or an oncogene in multiple cancers such hepatocellular carcinoma, pancreatic, bladder, colon and breast cancers (Li et al, 2019).…”
Section: Discussionmentioning
confidence: 99%
“…The human prostate adenocarcinoma cell line PC3 was purchased from CLS-Cell line services GmbH (Eppelheim, Germany). Cells were maintained in low glucose (5.5 mM) DMEM (Gibco/Thermo Fisher Scientific, Karlsruhe, Germany) supplemented with 5% fetal bovine serum (FBS) (Bio&Sell, Feucht, Germany) [ 19 ]. One day before treatment, medium was changed to DMEM with 0.2% FBS.…”
Section: Methodsmentioning
confidence: 99%